Rein Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $16.0M | $5.3M |
| FY2020 | — | $12.2M | $7.0M |
| FY2021 | — | $43.9M | $3.6M |
| FY2022 | — | $18.6M | $5.2M |
| FY2023 | — | $98.3M | $17.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $16.0M | $5.3M |
| FY2020 | — | $12.2M | $7.0M |
| FY2021 | — | $43.9M | $3.6M |
| FY2022 | — | $18.6M | $5.2M |
| FY2023 | — | $98.3M | $17.3M |